231 related articles for article (PubMed ID: 28970566)
21. Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization.
Meadows SA; Edosada CY; Mayeda M; Tran T; Quan C; Raab H; Wiesmann C; Wolf BB
Biochemistry; 2007 Apr; 46(15):4598-605. PubMed ID: 17381073
[TBL] [Abstract][Full Text] [Related]
22. The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma.
Bracke A; Van Elzen R; Van Der Veken P; Augustyns K; De Meester I; Lambeir AM
Clin Chim Acta; 2019 Aug; 495():154-160. PubMed ID: 30981844
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
Lai D; Ma L; Wang F
Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
[TBL] [Abstract][Full Text] [Related]
24. Targeting fibroblast activation protein in cancer - Prospects and caveats.
Busek P; Mateu R; Zubal M; Kotackova L; Sedo A
Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB
J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248
[TBL] [Abstract][Full Text] [Related]
26. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy.
Hamson EJ; Keane FM; Tholen S; Schilling O; Gorrell MD
Proteomics Clin Appl; 2014 Jun; 8(5-6):454-63. PubMed ID: 24470260
[TBL] [Abstract][Full Text] [Related]
27. The role of fibroblast activation protein in health and malignancy.
Fitzgerald AA; Weiner LM
Cancer Metastasis Rev; 2020 Sep; 39(3):783-803. PubMed ID: 32601975
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α.
Keane FM; Nadvi NA; Yao TW; Gorrell MD
FEBS J; 2011 Apr; 278(8):1316-32. PubMed ID: 21314817
[TBL] [Abstract][Full Text] [Related]
29. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation.
Chung KM; Hsu SC; Chu YR; Lin MY; Jiaang WT; Chen RH; Chen X
PLoS One; 2014; 9(2):e88772. PubMed ID: 24551161
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of the promoter of fibroblast activation protein.
Zhang J; Valianou M; Cheng JD
Front Biosci (Elite Ed); 2010 Jun; 2(3):1154-63. PubMed ID: 20515787
[TBL] [Abstract][Full Text] [Related]
33. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.
Ramirez-Montagut T; Blachere NE; Sviderskaya EV; Bennett DC; Rettig WJ; Garin-Chesa P; Houghton AN
Oncogene; 2004 Jul; 23(32):5435-46. PubMed ID: 15133496
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast activation protein and chronic liver disease.
Wang XM; Yao TW; Nadvi NA; Osborne B; McCaughan GW; Gorrell MD
Front Biosci; 2008 Jan; 13():3168-80. PubMed ID: 17981786
[TBL] [Abstract][Full Text] [Related]
36. Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.
Ryabtsova O; Jansen K; Van Goethem S; Joossens J; Cheng JD; Lambeir AM; De Meester I; Augustyns K; Van der Veken P
Bioorg Med Chem Lett; 2012 May; 22(10):3412-7. PubMed ID: 22525314
[TBL] [Abstract][Full Text] [Related]
37. Bioluminescent Probe for Monitoring Endogenous Fibroblast Activation Protein-Alpha.
Lin Y; Ma Z; Li Z; Gao Y; Qin X; Zhang Z; Wang G; Du L; Li M
Anal Chem; 2019 Dec; 91(23):14873-14878. PubMed ID: 31670506
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
39. Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor.
Jung HJ; Nam EH; Park JY; Ghosh P; Kim IS
Bioorg Med Chem Lett; 2021 Apr; 37():127846. PubMed ID: 33571650
[TBL] [Abstract][Full Text] [Related]
40. Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).
Jansen K; Heirbaut L; Verkerk R; Cheng JD; Joossens J; Cos P; Maes L; Lambeir AM; De Meester I; Augustyns K; Van der Veken P
J Med Chem; 2014 Apr; 57(7):3053-74. PubMed ID: 24617858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
